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Abstract
Background: Coronary artery disease (CAD) is one of the most important issues in modern medicine due to its high
mortality and prevalence. An early detection and prevention can reduce morbidity and mortality. Arterial stiffness is a
potent and independent predictor of CAD. We aimed to investigate the arterial stiffness in CAD patients undergoing
the coronary angiography. Also, we investigated a possible correlation between arterial stiffness and in-stent restenosis
(ISR), an important limitation of percutaneous coronary intervention (PCI).
Methods: The study included 160 patients undergoing coronary angiography, treated either with PCI or with CABG.
The pulse wave velocity (PWV) and augmentation index (AIx) were measured by the Arteriograph.
Results: PWV in the CAD group (12.24 ± 2.78 m/s) was significantly higher compared to the control group
(8.27 ± 1.89 m/s). PWV in ISR and left main (LM) stenosis group (14.03 ± 3.15 and 13.89 ± 2.95 m/s) was significantly higher
compared to the control and CAD groups. Peripheral and central AIx were significantly higher in CAD group (1.38 ± 30.
63 % and 38.35 ± 15.52 %) than in control group (−11.35 ± 26.74 % and 26.91 ± 10.62 %). Patients with LM
stenosis have significantly higher values of peripheral and central AIx (23.37 ± 23.77 % and 49.71 ± 12.02 %)
than the CAD and ISR group.
Conclusions: The study confirmed a positive correlation between arterial stiffness measures, PWV and AIx, and CAD.
Also, this study showed the correlation between PWV and ISR which can help to select more appropriate stent.
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Background
Coronary artery disease (CAD) is one of the most im-
portant issues in modern medicine due to high preva-
lence and mortality. Both, the prevention and treatment
of CAD in recent decades have been improved, however,
CAD remains the first inductor of morbidity and mortality
in humans [1]. An early detection and prevention of CAD
is very important and can reduce morbidity and mortality.
Numerous epidemiological and clinical studies showed a
positive correlation between CAD and male gender, high
blood pressure, diabetes, smoking, physical inactivity,
and hyperlipidemia [2]. In addition to these traditional
risk factors, the arterial stiffness defined as a direct
measure - aortic pulse wave velocity (PWV) and an in-
direct parameter - augmentation index (AIx), is a
strong and independent predictor of CAD and adverse
cardiovascular events [3, 4]. The majority of the current
research, investigating correlation between arterial stiff-
ness and CAD was of observational or epidemiological
nature [5, 6]. Only few clinical studies showed a direct
correlation between PWV and CAD diagnosed by coronary
angiography [7, 8].
Treatment of CAD could involve pharmacotherapy,
percutaneous coronary interventions (PCI), and surgical
revascularization. All methods are associated with some
limitations and disadvantages. In the past few decades
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the development of PCI, atherectomy, with bare-metal
(BMS) and drug eluting stents (DES) has made a signifi-
cant progress in the management of CAD [1]. The most
important limitation of PCI is thrombosis and in-stent
restenosis (ISR). The incidence of ISR after a BMS im-
plantation is 20–25 % in the first 6 months [9]. The de-
velopment of DES contributed to a significant reduction
of the ISR, as it decreased the incidence rate of ISR in
only 5–10 % cases [10–12]. However, the rate of DES
use is lower than 10 % in most countries due to the high
cost. The incidence of DES implantation in developing
countries, such as ours, is smaller than an average rate,
because of its higher cost.
Factors that contribute to ISR are not fully understood.
Cassese et al. showed that diabetes mellitus, multiple le-
sions, small vessels, multiple stents, smaller final stent
lumen diameter and stent design are predictors for ISR
[11, 13]. Some previous studies established a link between
arterial stiffness and ISR. Ueda et al. found a correlation
between AIx in the ascending aorta and ISR [14]. Also,
Nakayama et al. showed a correlation between pulse pres-
sure and ISR [15]. Recently, Mahfouz et al. described a
correlation between arterial stiffness measured with ultra-
sonography and ISR [16].
In this study we aimed to investigate the correlation be-
tween CAD assessed by coronary angiography graded by
SYNTAX score and arterial stiffness measured by Arterio-
graph, a simple, inexpensive, reproducible and investigator-
independent method. Also, we investigated the correlation
between ISR and aortic PWV and Aix.
Methods
The study included 160 patients with CAD who under-
went an elective coronary angiography in the Depart-
ment of Invasive Cardiology of Clinical Hospital Mostar
from 1st April 2014 to 1st October 2014. The control
group consisted of 59 sex and age-matched healthy
people. All subjects in the control group underwent the
clinical examination, ECG, stress test, echocardiography,
measuring of arterial stiffness and laboratory testing. All
those subjects had a clear medical history. The CAD
group excluded subjects with atrial fibrillation, acute
coronary syndrome, and with significant valvular disease.
All CAD patients had previous concordant non-invasive
findings for CAD and experienced angina pectoris. They
received an appropriate treatment (statines, beta blockers,
ACE inhibitors and aspirin) in accordance with the guide-
lines for CAD [17]. Out of a total number of CAD pa-
tients, 102 were treated with PCI and 58 underwent heart
surgery. During the next 6 months 23 patients had ISR in
BMS. All patients who underwent PCI had dual antiplate-
let therapy, aspirin and clopidogrel. The study was con-
ducted in accordance with the Helsinki Declaration and
approved by the Ethics Committee of the University
Hospital Mostar. All subjects gave written informed con-
sent to participate in this study.
Coronary angiography and SYNTAX score
All patients underwent routine coronary angiography
using the Judkins technique on digitized coronary angi-
ography equipment (Shimadzu, Kyoto, Japan). Coronary
angiograms were computerized and assessed by two ex-
perienced angiographers who were blinded to the results
of arterial stiffness measurements. A significant CAD
was defined as at least 50 % or more stenosis. ISR was
defined as >50 % diameter stenosis at the stent site.
The SYNTX score is a semi-quantitative angiographic
tool to determine the extent of CAD [18]. The algorithm
contains of 12 questions referring to the coronary anatomy
and total number and extent of coronary artery lesions.
The SYNTAX score was calculated for each coronary le-
sion producing a ≥50 % luminal obstruction in vessels with
a diameter of 1.5 mm or more. Patients were divided
according to 2-year rates of major adverse coronary
events as low (0–22), intermediate (23–32), and high
(≥33) risk group. The SYNTAX score was calculated
with a computer-based questionnaire program.
Measurements of arterial stiffness
Arterial stiffness was measured by an oscillometric
non-invasive device Arteriograph (TensioMed, Budapest,
Hungary). The device detects and processes oscillations
on the upper-arm positioned cuff by a special high fidelity
sensor during a complete occlusion of brachial artery.
Simultaneously with the parameters of arterial stiffness
(PWV (m/s) an AIx (%), the device also recorded systolic
and diastolic blood pressures and heart rate [19].
Twenty-four hours prior to the examination subjects
were asked to refrain from exercise, fruits, vegetables,
dietary supplements, tea, alcoholic beverages, and caffeine
containing foods. Also, 12 hours before measurement of
arterial stiffness patients did not take any drugs. All experi-
ments were carried out in a quiet, temperature controlled
room maintained around 24 °C and were started at 8 a.m.
The subjects had rested quietly for 15 min in the supine
position before the measurement.
Statistics
Data are expressed as mean ± SD. Statistical analyses
were performed using GraphPad Instat and GraphPad
Prism (San Diego, CA USA). All variables were normalized
before data statistical analyses on age, heart rate and blood
pressure. One-way ANOVA test was used to evaluate
changes in AIx and PWV. When statistical significance
was reached by ANOVA (P <0.05), Bonferroni test was
used for the post hoc analysis.
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Results
In this study we investigated the association of arterial
stiffness with CAD and correlation between degrees of
CAD measured by SYNTAX score. We found a strong
correlation between CAD and arterial stiffness, but no
association between degrees of the CAD with the parame-
ters of arterial stiffness. From CAD group we extracted
CABG, PCI, left main (LM) stenosis and ISR groups.
The general characteristics of control, CAD, ISR and
LM stenosis groups are shown in Table 1. In the control
and all experimental groups the male sex was dominant.
Also, in the CAD, ISR and LM stenosis group, patients
were slightly older with higher mean arterial pressure.
Aortic PWV in the CAD group (12.24 ± 2.78 m/s)
was significantly higher compared to the control group
(8.27 ± 1.89 m/s) (P <0.05). Also, PWV of an ISR and
LM stenosis group (14.03 ± 3.15 and 13.89 ± 2.95 m/s)
was significantly higher than in the control and CAD
group (P <0.05) (Fig. 1).
The central AIx in the CAD, ISR and LM stenosis
group (38.35 ± 15.52, 39.71 ± 13.97 and 49.71 ± 12.02 %,
respectively) was significantly higher compared to the
control group (26.91 ± 10.62 %) (P <0.05). Also, central
AIx of an LM stenosis group was significantly higher
than in the CAD and ISR group (P <0.05) (Fig. 2).
The peripheral AIx in the CAD, ISR and LM stenosis
group (1.38 ± 30.63 and 4.09 ± 27.60 and 23.37 ± 23.77 %,
respectively) was significantly higher compared to the
control group (−11.35 ± 26.74 %) (P <0.05). Also, peripheral
AIx of an LM stenosis group was significantly higher than
in the CAD and ISR group (P <0.05) (Fig. 3).
The SYNTAX score was significantly higher in pa-
tients who were referred for CABG and patients with
LM stenosis (34.62 ± 12.46 and 36.78 ± 16.47) compared
Table 1 General characteristics of control, CAD and ISR groups
Control group (n-58) CAD group (n-160) ISR group (n-23) LM stenosis group (n-9)
Age (year) 59.5 ± 5.4 61.5 ± 4.8 62.1 ± 6.1 63.8 ± 8.4
Male n (%) 43 (72.9) 115 (71.7) 22 (95.7) 9 (100)
Female n (%) 16 (27.1) 45 (28.3) 1 (4.3) 0 (0)
Smoking n (%) 21 (35.6) 82 (51.3) 8 (34.8) 6 (66.6)
Cholesterol (mmol/L) 5.59 ± 1.45 5.38 ± 1.33 5.06 ± 1.56 5.45 ± 1.73
LDL (mmol/L) 3.84 ± 0.78 3.66 ± 0.51 3.58 ± 0.68 3.78 ± 1.44
HDL (mmol/L) 1.02 ± 0.43 1.08 ± 0.25 1.13 ± 0.58 1.06 ± 0.29
Triglycerides (mmol/L) 2.12 ± 0.91 1.92 ± 0.77 1.84 ± 0.98 1.79 ± 0.43
Heart rate (beats/min) 65.7 ± 6.1 64.1 ± 4,2 65.1 ± 9,7 64.7 ± 8,9
Mean blood pressure (mm Hg) 101.3 ± 5.6 104.6 ± 6,5 105.7 ± 8.9 106.1 ± 9.6
Diabetes mellitus n (%) 0.0 (0.0) 25 (15.7) 3 (13.0) 0 (0)
Glucose blood level (mmol/L) 5.17 ± 0.67 5.71 ± 1.73 8.23 ± 0.72 5.34 ± 0.89
Renal failure n (%) 0.0 (0.0) 6 (3.75) 1 (4.3) 1 (11,1)
Creatinine (μmol/L) 94.22 ± 22.96 98.30 ± 26.04 143 109.78 ± 32.12
SYNTAX scores 25.27 ± 4.1 19.33 ± 6.9 36.78 ± 14.47
Multiple stents n (%) 14 (16.1) 4 (17.3)
Stent diameter (mm) 3.01 ± 0.78 3.09 ± 0.93
Length of stent (mm) 18.4 ± 0.58 18.1 ± 2.42
Data are shown as mean value ± SD
CAD coronary artery disease, HDL low-density lipoprotein, ISR in-stent restenosis, LM left main, LDL high-density lipoprotein, SD standard deviation
Fig. 1 The values of aortic pulse wave velocity (PWV) in the control,
coronary artery disease (CAD), in-stent restenosis (ISR) and left main
stenosis group. Data are shown as mean ± SD, * p <0.05 vs control
group, # p <0.05 vs CAD group
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to the PCI and ISR group (17.63 ± 9.77 and 19.33 ± 6.9)
(P <0.05). Among patients treated with PCI and patients
who underwent CABG we did not find a difference in
the parameters of arterial stiffness (CABG vs PCI
group; PWV 12.23 ± 2.93 vs 12.26 ± 2.68 m/s; central
Aix 37.93 ± 14.36 vs 38.47 ± 15.39 %; peripheral AIx
1.35 ± 28.32 vs 1.57 ± 30.38 %) (Additional file 1).
Discussion
In this study we showed a positive correlation between
arterial stiffness parameters and CAD proved with coronary
angiography. Also, our study showed the correlation
between PWV and ISR.
Some previous studies showed the correlation between
arterial stiffness and CAD [20–22]. In the most of them
CAD was proved with non-invasive methods. Several
studies demonstrated the correlation between CAD ex-
amined with coronary angiography and arterial stiffness.
Liu et al. showed positive correlation between arterial stiff-
ness measured by Sphygmocor and CAD proved with
multi slice computed tomography coronary angiography
[23]. Imanishi et al. concluded that high brachial–ankle
PWV is an independent predictor for the presence of
CAD, especially in men [24]. Contrary to our investiga-
tion, the arterial stiffness in the mentioned studies was
proved with different devices and at different blood vessels
or coronary artery disease was not identified at coronary
angiography. Only one study investigated the correlation
between CAD and PWV measured by Arteriograph.
Similar to our study, they found the positive correlation
between CAD examined with coronary angiography
and arterial stiffness [7]. However, despite high differ-
ences between PWV and AIx in the control and CAD
group, we also did not find the correlation between the
CAD grades (defined by SYNTAX score) with PWV
and AIx. But still, in this study we proved a correlation
between arterial stiffness and left main stenosis. However,
Cho et al. showed the correlation between AIx and the
grade of CAD in patients aged less than 65 years, but not
in the older ones [25]. The correlation was not found in
patients above 65 years. In our opinion, it is not realistic
to expect that even this method can determine the level of
CAD. Also, the measuring of arterial elasticity is de-
veloped in order to asses an increased cardiovascular
risk but some other specific methods should be used
to confirm and prove CAD.
Furthermore, we investigated a correlation between
ISR and arterial stiffness. The correlation between PWV
and ISR was found, but not between AIx and ISR. Arterial
stiffness is strongly dependent on the balance of two major
proteins, elastin and collagen [26]. Normally, there is a
tightly regulated balance between synthesis and degrad-
ation of these two proteins. Therefore, if there is an in-
creased collagen production and reduced degradation in
the whole vascular system, arterial stiffness will be in-
creased and more likely an ISR will occur [27]. After
the stent insertion some inflammatory changes in the
coronary artery wall such as endothelial degradation,
macrophage infiltration and smooth muscle cell prolifera-
tion could occur. Also, the inflammation in arteries in-
creases the extracellular matrix proteins and collagen
synthesis contributing to the ISR [28, 29]. BMS causes
Fig. 2 The values of aortic augmentation index (AIx), expressed in
percentages in the control, coronary artery disease (CAD), in stent
restenosis (ISR) and left main stenosis group. Data are shown as
mean ± SD, * p <0.05 vs control group, # p <0.05 vs CAD and
ISR groups
Fig. 3 The difference between the brachial augmentation index (AIx)
in control, coronary artery disease (CAD), in stent restenosis (ISR) and
left main stenosis group. Data are shown as mean ± SD, * p <0.05 vs
control group, # p <0.05 vs CAD and ISR groups
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neointimal hyperplasia after implantation and leads to ISR
and reintervention in more than 20 % of patients by
6 months [10, 11]. Similarly to our study, Ueda et al.
showed the correlation between aortic stiffness and re-
stenosis after balloon angioplasty [30]. However, mecha-
nisms including collagen turnover in ISR and restenosis
after balloon angioplasty are different. Stenting causes an
even greater increase in collagen accumulation compared
with balloon angioplasty [28, 31, 32]. Accordingly, the
same author showed the correlation between aortic AIx
and ISR [14], although the correlation between Aix and
ISR was not found in our study. Recently, Mahfouz et al.
proved the association of ISR and arterial elasticity [16].
All studies that have found a correlation between the ex-
tent of ISR and arterial stiffness were performed with vari-
ous devices and methods. All results can contribute to a
better understanding of ISR and help to make a decision
considering stent implantation. In the cases of high PWV
and other risks factors for ISR a cardiologist may be
guided to implant DES. Moreover, this could be very use-
ful in a cath lab with limited finances.
Conclusion
Our results confirm the importance of measuring arterial
elasticity in patients with CAD predisposition. Also, we
have found that an elevated PWV is associated with ISR
suggesting its measuring before the procedure which con-
tributes for a better selection of the stent implant. This
study confirms the value of Arteriograph in cardiovascular
risk assessment as a broadly applicable method for
screening the general population.
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